WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H598418
CAS#: 121650-80-4
Description: Pancopride is a selective 5-HT3 receptor antagonist; effective against anticancer drug-evoked emesis.
Hodoodo Cat#: H598418
Name: Pancopride
CAS#: 121650-80-4
Chemical Formula: C18H24ClN3O2
Exact Mass: 349.16
Molecular Weight: 349.850
Elemental Analysis: C, 61.80; H, 6.91; Cl, 10.13; N, 12.01; O, 9.15
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Pancopride; Pancopridum; LAS 30451; LAS-30451; LAS30451;
IUPAC/Chemical Name: 4-amino-5-chloro-2-(cyclopropylmethoxy)-N-(quinuclidin-3-yl)benzamide
InChi Key: DBQMQBCSKXTCIJ-UHFFFAOYSA-N
InChi Code: InChI=1S/C18H24ClN3O2/c19-14-7-13(17(8-15(14)20)24-10-11-1-2-11)18(23)21-16-9-22-5-3-12(16)4-6-22/h7-8,11-12,16H,1-6,9-10,20H2,(H,21,23)
SMILES Code: O=C(NC1CN2CCC1CC2)C3=CC(Cl)=C(N)C=C3OCC4CC4
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 349.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Dewland P, Pérez Campos A, Martinez-Tobed A. Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers. Arzneimittelforschung. 1995 Feb;45(2):177-83. PubMed PMID: 7710444.
2: Grande L, Lacima G, Pérez A, Zayas JM. Lack of effect of a 5-HT3 antagonist, pancopride, on lower oesophageal sphincter pressure in volunteers. Br J Clin Pharmacol. 1995 Oct;40(4):401-3. PubMed PMID: 8554943; PubMed Central PMCID: PMC1365160.
3: Fernández AG, Puig J, Beleta J, Doménech T, Bou J, Berga P, Gristwood RW, Roberts DJ. Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis. Eur J Pharmacol. 1992 Nov 10;222(2-3):257-64. PubMed PMID: 1451737.
4: Salva P, Costa J, Pérez-Campos A, Martínez-Tobed A. Repeated dose pharmacokinetics of pancopride in human volunteers. Biopharm Drug Dispos. 1994 Nov;15(8):643-51. PubMed PMID: 7888596.
5: Aranda E, Barneto IC, Rubio MJ, Gonzalez R, Garcia A, Perez A. Prevention of highly emetogenic chemotherapy-induced vomiting: a double blind, randomized crossover study to compare pancopride (LAS 30451) and pancopride plus dexamethasone. Tumori. 1995 Nov-Dec;81(6):432-4. PubMed PMID: 8804470.
6: Pérez Campos A. [The clinical development of an antiemetic in oncology. A meta-analysis]. Med Clin (Barc). 1994 Sep 17;103(8):281-6. Spanish. PubMed PMID: 7967877.
7: Martin M, Rosell R, Guillem V, Díaz-Rubio E, Moreno I, Soriano V, Fernández A, Pérez A. LAS 30451: a novel 5-HT3 antagonist. Eur J Cancer. 1993;29A Suppl 1:S33-4. PubMed PMID: 8427723.